Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.
Tundidor I, Seijo-Vila M, Blasco-Benito S, Rubert-Hernández M, Adámez S, Andradas C, Manzano S, Álvarez-López I, Sarasqueta C, Villa-Morales M, González-Lois C, Ramírez-Medina E, Almoguera B, Sánchez-López AJ, Bindila L, Hamann S, Arnold N, Röcken C, Heras-Murillo I, Sancho D, Moreno-Bueno G, Caffarel MM, Guzmán M, Sánchez C, Pérez-Gómez E. Tundidor I, et al. Among authors: guzman m. Nat Commun. 2023 May 30;14(1):3130. doi: 10.1038/s41467-023-38750-9. Nat Commun. 2023. PMID: 37253733 Free PMC article.
Cannabinoids and cell fate.
Guzmán M, Sánchez C, Galve-Roperh I. Guzmán M, et al. Pharmacol Ther. 2002 Aug;95(2):175-84. doi: 10.1016/s0163-7258(02)00256-5. Pharmacol Ther. 2002. PMID: 12182964 Review.
Hypothesis: cannabinoid therapy for the treatment of gliomas?
Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Guzmán M. Velasco G, et al. Among authors: guzman m. Neuropharmacology. 2004 Sep;47(3):315-23. doi: 10.1016/j.neuropharm.2004.04.016. Neuropharmacology. 2004. PMID: 15275820 Review.
Cannabinoids and ceramide: two lipids acting hand-by-hand.
Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Haro A, Guzmán M. Velasco G, et al. Among authors: guzman m. Life Sci. 2005 Aug 19;77(14):1723-31. doi: 10.1016/j.lfs.2005.05.015. Life Sci. 2005. PMID: 15958274 Review.
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.
Caffarel MM, Andradas C, Mira E, Pérez-Gómez E, Cerutti C, Moreno-Bueno G, Flores JM, García-Real I, Palacios J, Mañes S, Guzmán M, Sánchez C. Caffarel MM, et al. Among authors: guzman m. Mol Cancer. 2010 Jul 22;9:196. doi: 10.1186/1476-4598-9-196. Mol Cancer. 2010. PMID: 20649976 Free PMC article.
Towards the use of cannabinoids as antitumour agents.
Velasco G, Sánchez C, Guzmán M. Velasco G, et al. Among authors: guzman m. Nat Rev Cancer. 2012 May 4;12(6):436-44. doi: 10.1038/nrc3247. Nat Rev Cancer. 2012. PMID: 22555283 Review.
Cannabinoids: a new hope for breast cancer therapy?
Caffarel MM, Andradas C, Pérez-Gómez E, Guzmán M, Sánchez C. Caffarel MM, et al. Among authors: guzman m. Cancer Treat Rev. 2012 Nov;38(7):911-8. doi: 10.1016/j.ctrv.2012.06.005. Epub 2012 Jul 7. Cancer Treat Rev. 2012. PMID: 22776349 Review.
Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.
Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI, Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C. Moreno E, et al. Among authors: guzman m. J Biol Chem. 2014 Aug 8;289(32):21960-72. doi: 10.1074/jbc.M114.561761. Epub 2014 Jun 18. J Biol Chem. 2014. PMID: 24942731 Free PMC article.
1,528 results